Published in Drugs on January 01, 1992
Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22
Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care (1991) 9.95
Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med (1988) 7.22
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Progression of incipient diabetic retinopathy during good glycemic control. Diabetes (1987) 3.30
Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med (1987) 2.50
Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care (1980) 1.98
Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care (1987) 1.83
Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care (1980) 1.71
Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia (1991) 1.43
Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM. Diabetes Care (1991) 1.32
Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs (1988) 1.28
Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models. Diabetes Care (1991) 1.07
Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. American Diabetes Association. Diabetes Care (1989) 1.01
Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care (1991) 1.01
Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes Care (1989) 0.90
Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas. Diabetes Care (1990) 0.87
Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors. Drugs (1992) 0.85
A prospective study of peripheral occlusive arterial disease in diabetes. III. Initial lipid and lipoprotein findings. Mayo Clin Proc (1981) 0.83
Detection of pancreatic islet tissue following islet allotransplantation in man. Transplantation (1991) 0.79
Influence of the degree of control of diabetes on the prevention, postponement and amelioration of late complications. Drugs (1989) 0.78
Acarbose treatment and diabetic nephropathy in the Cohen diabetic rat. Horm Metab Res (1990) 0.78
Effects of acarbose on serum lipoproteins in healthy individuals during prolonged administration of a fiber-free formula diet. Ann Nutr Metab (1989) 0.78
Metabolic effects of acarbose in young healthy men. Eur J Clin Nutr (1989) 0.78
Current status of aldose reductase inhibitors. Diabetes Care (1987) 0.77